June 5, 2017 - By Adrian Erickson
The stock of Vitamin Shoppe Inc (NYSE:VSI) is a huge mover today! About 111,039 shares traded. Vitamin Shoppe Inc (NYSE:VSI) has declined 57.70% since June 5, 2016 and is downtrending. It has underperformed by 74.40% the S&P500.The move comes after 5 months positive chart setup for the $258.12 million company. It was reported on Jun, 5 by Barchart.com. We have $11.79 PT which if reached, will make NYSE:VSI worth $7.74 million more.
Obermeyer Wood Investment Counsel Lllp decreased Unitedhealth Group Inc (UNH) stake by 10.45% reported in 2016Q4 SEC filing. Obermeyer Wood Investment Counsel Lllp sold 24,349 shares as Unitedhealth Group Inc (UNH)’s stock rose 9.50%. The Obermeyer Wood Investment Counsel Lllp holds 208,621 shares with $33.39 million value, down from 232,970 last quarter. Unitedhealth Group Inc now has $173.25 billion valuation. The stock rose 0.32% or $0.58 reaching $179.97. About 792,883 shares traded. UnitedHealth Group Inc (NYSE:UNH) has risen 32.76% since June 5, 2016 and is uptrending. It has outperformed by 16.06% the S&P500.
Among 11 analysts covering Vitamin Shoppe (NYSE:VSI), 1 have Buy rating, 2 Sell and 8 Hold. Therefore 9% are positive. Vitamin Shoppe has $41 highest and $19 lowest target. $31.63’s average target is 176.24% above currents $11.45 stock price. Vitamin Shoppe had 19 analyst reports since August 6, 2015 according to SRatingsIntel. Barclays Capital initiated Vitamin Shoppe Inc (NYSE:VSI) on Friday, September 23 with “Equal Weight” rating. The stock of Vitamin Shoppe Inc (NYSE:VSI) has “Underweight” rating given on Tuesday, January 17 by Morgan Stanley. JP Morgan downgraded Vitamin Shoppe Inc (NYSE:VSI) on Thursday, October 27 to “Neutral” rating. The stock has “Sell” rating by Goldman Sachs on Thursday, January 19. Deutsche Bank maintained Vitamin Shoppe Inc (NYSE:VSI) on Thursday, November 5 with “Hold” rating. Zacks upgraded the stock to “Sell” rating in Saturday, August 8 report. Deutsche Bank maintained it with “Hold” rating and $41 target in Thursday, August 6 report. Wedbush initiated Vitamin Shoppe Inc (NYSE:VSI) rating on Thursday, April 21. Wedbush has “Outperform” rating and $39 target. The company was upgraded on Thursday, May 11 by Morgan Stanley. On Thursday, November 3 the stock rating was downgraded by Morgan Stanley to “Equal-Weight”.
Vitamin Shoppe, Inc. is a multi-channel specialty retailer and contract maker of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The company has market cap of $258.12 million. The Firm operates through three divisions: retail, direct and manufacturing. It has a 14.95 P/E ratio. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.
Analysts await UnitedHealth Group Inc (NYSE:UNH) to report earnings on July, 18. They expect $2.38 EPS, up 21.43% or $0.42 from last year’s $1.96 per share. UNH’s profit will be $2.29B for 18.90 P/E if the $2.38 EPS becomes a reality. After $2.37 actual EPS reported by UnitedHealth Group Inc for the previous quarter, Wall Street now forecasts 0.42% EPS growth.
Among 20 analysts covering UnitedHealth Group (NYSE:UNH), 20 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. UnitedHealth Group had 29 analyst reports since September 2, 2015 according to SRatingsIntel. The rating was upgraded by Argus Research to “Buy” on Friday, July 22. The firm earned “Overweight” rating on Wednesday, September 16 by JP Morgan. The stock of UnitedHealth Group Inc (NYSE:UNH) has “Neutral” rating given on Wednesday, November 9 by Mizuho. Citigroup initiated the stock with “Buy” rating in Friday, October 2 report. The rating was maintained by Cantor Fitzgerald with “Overweight” on Friday, April 7. The stock of UnitedHealth Group Inc (NYSE:UNH) has “Buy” rating given on Friday, November 20 by Mizuho. The firm has “Buy” rating given on Friday, April 8 by Cleveland. The stock of UnitedHealth Group Inc (NYSE:UNH) earned “Outperform” rating by Credit Suisse on Wednesday, December 16. The stock has “Buy” rating by Mizuho on Wednesday, November 30. Cantor Fitzgerald upgraded the shares of UNH in report on Wednesday, December 7 to “Buy” rating.
Investors sentiment increased to 1.07 in 2016 Q4. Its up 0.05, from 1.02 in 2016Q3. It improved, as 37 investors sold UNH shares while 473 reduced holdings. 135 funds opened positions while 411 raised stakes. 804.47 million shares or 1.08% more from 795.86 million shares in 2016Q3 were reported. Putnam Fl Mngmt has invested 1.48% in UnitedHealth Group Inc (NYSE:UNH). Muhlenkamp Commerce invested in 2.99% or 59,095 shares. Twin Mngmt holds 0.96% of its portfolio in UnitedHealth Group Inc (NYSE:UNH) for 93,310 shares. First Manhattan invested in 0.29% or 301,508 shares. Moreover, Clearbridge Limited Liability Co has 1.66% invested in UnitedHealth Group Inc (NYSE:UNH). Ontario Teachers Pension Plan Board, a Ontario – Canada-based fund reported 64,318 shares. Beech Hill Advsr holds 0.21% in UnitedHealth Group Inc (NYSE:UNH) or 2,156 shares. Tompkins holds 0.2% or 4,675 shares in its portfolio. Fred Alger Mgmt holds 2.19% in UnitedHealth Group Inc (NYSE:UNH) or 2.51M shares. Independent Port Consultants has invested 0.06% in UnitedHealth Group Inc (NYSE:UNH). Winch Advisory Services Ltd Liability Company accumulated 331 shares or 0.04% of the stock. Clifford Swan Investment Counsel Ltd Com owns 7,510 shares. Goldman Sachs Grp accumulated 0.21% or 4.65M shares. Advantus Cap Management reported 95,771 shares or 0.41% of all its holdings. Hgk Asset Mngmt holds 99,056 shares or 2.16% of its portfolio.
Since December 6, 2016, it had 0 insider buys, and 8 selling transactions for $31.99 million activity. Another trade for 5,310 shares valued at $861,885 was sold by WILENSKY GAIL R. 2,000 shares were sold by ROOS THOMAS E, worth $315,203 on Tuesday, December 6. The insider BURKE RICHARD T sold $2.40M. The insider BALLARD WILLIAM C JR sold 5,000 shares worth $813,400. The insider HOOPER MICHELE J sold $2.56M.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.